encyclopedia of medical concepts
ψ 
ψ 
ψ 

Medigoxin

More information in Books or onNLM PubMed
Definition: A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE).     
Pharmacological Action Anti-Arrhythmia Agents; Cardiotonic Agents; Enzyme Inhibitors 		Other names beta-Methyldigoxin; Metildigoxin; beta Methyldigoxin; 4''' O Methyldigoxin; Roche Brand of Medigoxin; Methyldigoxin; Medixin; Lanitop; Lanirapid; Kern Brand of Medigoxin; Bemecor; 4'''-O-Methyldigoxin

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy